Osteoporosis and its precursor, osteopenia, represent a significant and often underdiagnosed public health burden. Characterised by reduced bone mineral density (BMD) and deterioration of bone microarchitecture, these conditions substantially increase the risk of fragility fractures — with profound consequences for morbidity, mortality, and quality of life. Nutritional and supplemental intervention plays a critical and evidence-supported role in both prevention and adjunctive management.
Definitions and Diagnostic Criteria
Bone mineral density is assessed via dual-energy X-ray absorptiometry (DEXA) and expressed as a T-score — the number of standard deviations above or below the mean BMD of a healthy young adult reference population:
- Normal: T-score ≥ −1.0
- Osteopenia: T-score between −1.0 and −2.5
- Osteoporosis: T-score ≤ −2.5
- Severe osteoporosis: T-score ≤ −2.5 with one or more fragility fractures
Osteopenia represents a clinically important window of opportunity — intervention at this stage can prevent progression to osteoporosis and significantly reduce fracture risk.
Pathophysiology
Bone is a dynamic tissue undergoing continuous remodelling through the coordinated activity of osteoblasts (bone formation) and osteoclasts (bone resorption). Osteoporosis develops when resorption chronically exceeds formation, resulting in net bone loss. Key contributing mechanisms include:
- Oestrogen deficiency — the primary driver of postmenopausal bone loss. Oestrogen normally suppresses osteoclast activity; its decline accelerates resorption, with bone loss of 2–3% per year in the first 5–10 years post-menopause.
- Age-related decline in osteoblast activity — reduced bone formation capacity with advancing age, independent of hormonal status.
- Calcium and vitamin D insufficiency — inadequate calcium intake stimulates parathyroid hormone (PTH) secretion, which mobilises calcium from bone. Vitamin D deficiency impairs intestinal calcium absorption and further elevates PTH.
- Chronic inflammation — pro-inflammatory cytokines (IL-1, IL-6, TNF-α) upregulate RANKL, promoting osteoclastogenesis and accelerating bone resorption.
- Sarcopenia — age-related muscle loss reduces mechanical loading on bone, a key stimulus for bone formation. Muscle and bone health are intimately linked.
- Gut microbiome dysbiosis — emerging evidence links altered gut flora to impaired calcium absorption and systemic inflammation, both of which negatively impact bone metabolism.
Risk Factors
Key risk factors for osteoporosis and osteopenia include:
- Female sex and postmenopausal status
- Advanced age (>65 years in women, >70 years in men)
- Low body weight or BMI
- Family history of osteoporosis or fragility fracture
- Prolonged corticosteroid use
- Smoking and excessive alcohol consumption
- Sedentary lifestyle and low mechanical loading
- Malabsorption syndromes (coeliac disease, inflammatory bowel disease)
- Hyperthyroidism, hyperparathyroidism, and other endocrine disorders
- Chronic use of proton pump inhibitors (PPIs), which impair calcium absorption
Evidence-Based Nutritional and Supplemental Support
Nutritional intervention is foundational to both the prevention and adjunctive management of osteoporosis and osteopenia. The following supplements are stocked in our dispensary and selected for their clinical evidence base:
Calcium — The Primary Structural Mineral of Bone
Calcium constitutes approximately 70% of bone mineral content. Calcium citrate and citrate/malate forms are preferred over carbonate in individuals with reduced gastric acid production (common with age and PPI use), as they do not require an acidic environment for absorption. Calcium should always be co-administered with vitamin D to optimise intestinal absorption.
👉 Pure Encapsulations Calcium Citrate
👉 Pure Encapsulations Calcium Magnesium Citrate
👉 Pure Encapsulations Calcium Magnesium Citrate/Malate
👉 Doctor's Best Calcium Bone Maker Complex
👉 Solgar Calcium Magnesium plus Boron
👉 HealthZone Bone Zone 60tabs
Vitamin D3 — Essential for Calcium Absorption and Bone Mineralisation
Vitamin D3 (cholecalciferol) is critical for intestinal calcium and phosphate absorption, bone mineralisation, and PTH regulation. Deficiency is highly prevalent in New Zealand, particularly in winter months and in older adults with limited sun exposure. Clinical guidelines generally recommend 1000–2000 IU/day for bone health maintenance, with higher doses under practitioner supervision for deficiency correction. Vitamin K2 (MK-7) is an important co-factor, directing calcium into bone rather than soft tissue.
👉 Pure Encapsulations Vitamin D3 Liquid
👉 Pure Encapsulations Vitamin D3 1000 IU
👉 Designs For Health D3 Supreme 240caps
👉 Biotrace Phyto D3 Complex 60caps
Magnesium — Cofactor in Bone Mineralisation and Vitamin D Metabolism
Magnesium is required for the conversion of vitamin D to its active form and is a structural component of the bone mineral matrix. Approximately 60% of the body's magnesium is stored in bone. Deficiency impairs osteoblast function and has been associated with lower BMD in epidemiological studies.
👉 Designs For Health Magnesium Glycinate Complex 60caps
👉 Coyne Magnesium Citrate Liposomal 60vc
Creatine Monohydrate — Muscle-Bone Coupling and Emerging Bone Evidence
Creatine is best known for its role in ATP regeneration and muscle performance, but its relevance to bone health is increasingly recognised. Given the intimate mechanical coupling between muscle and bone — where muscle contraction generates the loading forces that stimulate osteoblast activity — creatine's ability to increase muscle mass, strength, and power output translates directly into greater mechanical stimulus for bone formation. Emerging clinical evidence also suggests creatine may have direct effects on bone metabolism, with studies in postmenopausal women demonstrating improvements in bone geometry and reduced bone resorption markers when combined with resistance training.
👉 Pure Encapsulations Creatine
👉 Designs For Health Creatine 450gm
👉 RN Labs Creatine Monohydrate Powder
HMB (Beta-Hydroxy Beta-Methylbutyrate) — Anti-Catabolic Muscle and Bone Support
HMB is a metabolite of the essential amino acid leucine and is one of the most clinically studied compounds for the preservation of lean muscle mass in older adults. Its relevance to bone health operates primarily through the muscle-bone axis: by attenuating muscle protein breakdown (proteolysis) and stimulating muscle protein synthesis, HMB preserves the mechanical loading forces on bone that are essential for osteoblast activation and bone formation. Clinical trials in older adults have demonstrated that HMB supplementation — particularly when combined with vitamin D and resistance exercise — significantly reduces muscle loss, improves functional strength, and may attenuate bone resorption markers. HMB is particularly indicated in individuals with sarcopenia, prolonged immobility, or corticosteroid-induced muscle wasting. Please contact our team to enquire about HMB availability in our dispensary.
Collagen Peptides — Supporting the Organic Bone Matrix
Bone is approximately 30% organic matrix, of which type I collagen constitutes the majority. Hydrolysed collagen peptides have demonstrated in clinical trials the ability to stimulate osteoblast activity, increase bone collagen synthesis, and improve BMD markers — particularly when combined with calcium and vitamin D.
👉 Designs for Health Whole Beauty Collagen 180gm
Omega-3 Fatty Acids — Anti-Inflammatory Bone Protection
EPA and DHA reduce the production of pro-inflammatory cytokines that upregulate osteoclast activity. Epidemiological studies have associated higher omega-3 intake with greater BMD, and clinical trials have demonstrated modest but significant improvements in bone turnover markers with supplementation.
👉 BePure Three Fish Oil
👉 Nordic Naturals Arctic-D Cod Liver Oil 237ml — providing EPA, DHA, and vitamin D3 in a single premium formula, particularly beneficial for bone health in vitamin D-deficient individuals.
Lifestyle Considerations
Supplementation should be integrated within a comprehensive bone health strategy that includes:
- Weight-bearing and resistance exercise — the most potent non-pharmacological stimulus for bone formation. Aim for 3–4 sessions per week combining impact activity (walking, jogging) and progressive resistance training.
- Adequate dietary protein — protein provides the amino acid substrates for collagen synthesis and supports muscle mass, which is mechanically coupled to bone health.
- Fall prevention — particularly important in older adults; balance training, home hazard assessment, and vision correction are key components.
- Avoidance of bone-depleting factors — smoking cessation, alcohol moderation, and review of medications that impair bone metabolism (corticosteroids, PPIs, anticonvulsants).
Clinical Considerations and Monitoring
Osteoporosis and osteopenia management should be guided by a qualified healthcare practitioner. Baseline and follow-up DEXA scanning is recommended to monitor BMD response to intervention. Relevant investigations include serum 25-OH vitamin D, calcium, PTH, bone turnover markers (P1NP, CTX), and renal function.
Pharmacological therapy (bisphosphonates, denosumab, hormone replacement therapy) may be indicated in moderate-to-high fracture risk individuals and should be considered alongside nutritional intervention rather than as a replacement for it.
For personalised supplement recommendations tailored to your bone health needs, please contact our team or consult your healthcare provider.
Disclaimer: This article is intended for informational and educational purposes only and does not constitute medical advice. Always consult a qualified health professional before commencing any supplementation programme, particularly if you are taking prescription medications or have been diagnosed with a bone condition.